(2S)-1-tert-butylsulfanyl-2,4-dimethylpentan-2-amine;methane;(4S)-4-methyl-4-(2-methylpropyl)-1,3-oxazolidin-2-one
C21H48N2O2S — CID 159220512
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-1-tert-butylsulfanyl-2,4-dimethylpentan-2-amine;methane;(4S)-4-methyl-4-(2-methylpropyl)-1,3-oxazolidin-2-one
(2S)-1-tert-butylsulfanyl-2,4-dimethylpentan-2-amine;methane;(4S)-4-methyl-4-(2-methylpropyl)-1,3-oxazolidin-2-one (PubChem CID 159220512) has the molecular formula C21H48N2O2S and a molecular weight of 392.69 g/mol. Its IUPAC name is (2S)-1-tert-butylsulfanyl-2,4-dimethylpentan-2-amine;methane;(4S)-4-methyl-4-(2-methylpropyl)-1,3-oxazolidin-2-one.
Molecular Properties
| Compound Name | (2S)-1-tert-butylsulfanyl-2,4-dimethylpentan-2-amine;methane;(4S)-4-methyl-4-(2-methylpropyl)-1,3-oxazolidin-2-one |
|---|---|
| PubChem CID | 159220512 |
| Molecular Formula | C21H48N2O2S |
| Molecular Weight | 392.69 g/mol |
| Exact Mass | 392.34 |
| IUPAC Name | (2S)-1-tert-butylsulfanyl-2,4-dimethylpentan-2-amine;methane;(4S)-4-methyl-4-(2-methylpropyl)-1,3-oxazolidin-2-one |
| SMILES | C.C.CC(C)C[C@@]1(C)COC(=O)N1.CC(C)C[C@](C)(N)CSC(C)(C)C |
| InChI | InChI=1S/C11H25NS.C8H15NO2.2CH4/c1-9(2)7-11(6,12)8-13-10(3,4)5;1-6(2)4-8(3)5-11-7(10)9-8;;/h9H,7-8,12H2,1-6H3;6H,4-5H2,1-3H3,(H,9,10);2*1H4/t11-;8-;;/m00../s1 |
| InChIKey | KRPVCCQUUGLXQO-VBZBFRRBSA-N |
| XLogP | 6.08 |
| TPSA | 64.35 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 392.69 |
| LogP ≤ 5 | 6.08 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159220512 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.